Ayala Pharmaceuticals, Inc. ADXS
Set alert
0.60 USD 0.00 0.00%
At close · Feb 4
0.0846 Day range 0.60355
0.0011 52-week range 0.801
- YTD
- +1,405.11%
- 1 year
- +2,014.01%
- Open
- 0.0996
- Prev close
- 0.60355
- Mkt cap
- 25.71M
- Vol
- 10.01K
- Avg vol
- 5.05K
- EPS
- -7.99
- P/E
- -0.08
- Div yield
- 0.00%
More statistics
- Low
- 0.0846
- High
- 0.60355
- Forward P/E
- -1.03
- Beta
- 2.05
- Short ratio
- 0.64
- Inst. own
- 11.50%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 19, 2024
- 50-d avg
- 0.31906
- 200-d avg
- 0.445205
- 1y target
- 0.00
Analyst view
Consensus: buy
Buy
Price target (mean) 0.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy2
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 1
- 2 months ago 1
- 3 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | -0.10 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | -0.09 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 2.99M | +1081.8% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 25, 2020 | H.C. Wainwright | Downgrade | Buy | Neutral |
| Nov 25, 2020 | Jefferies | Downgrade | Buy | Hold |
| Nov 25, 2020 | H.C. Wainwright | Maintained | Buy | Buy |
| Nov 25, 2020 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Nov 25, 2020 | Barclays | Maintained | — | Overweight |
| Nov 25, 2020 | Barclays | Maintained | — | Overweight |
| Nov 25, 2020 | Barclays | Initiated | — | Overweight |
| Nov 25, 2020 | H.C. Wainwright | Maintained | — | Buy |
| Nov 25, 2020 | Jefferies | Initiated | — | Buy |
| Nov 25, 2020 | Janney Capital | Initiated | — | Buy |
| Nov 25, 2020 | MLV & Co. | Initiated | — | Buy |